Taxol induces caspase-10-dependent apoptosis

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Taxol (paclitaxel) is a chemotherapy agent known to inhibit cancer cell growth and induce apoptosis.
• The precise molecular mechanisms underlying Taxol-induced apoptosis remain incompletely understood.

Purpose of the Study:

• To elucidate the mechanism of Taxol-induced apoptosis in CCRF-HSB-2 human lymphoblastic leukemia cells.
• To investigate the roles of death receptors, FAS-associated death domain protein (FADD), caspases, and reactive oxygen species (ROS) in this process.

Main Methods:

• Cells were treated with Taxol and analyzed for apoptosis.
• Investigated the involvement of death receptors (Fas, TNF-R1, DR4, DR5) using neutralizing antibodies.
• Assessed the role of FADD via dominant-negative plasmid transfection.
• Analyzed caspase activation (caspase-10, -8, -6, -3, -9), substrate cleavage, and protein levels (FLIP, XIAP).
• Measured mitochondrial membrane potential (Deltapsim) and ROS generation.

Main Results:

• Taxol-induced apoptosis was independent of Fas, TNF-R1, DR4, and DR5 but dependent on FADD.
• Taxol activated caspase-10, caspase-8, caspase-6, and caspase-3, cleaving key substrates like Bcl-2 and PARP.
• Caspase-9 activation and direct ROS involvement were not observed.
• Caspase-10 inhibition completely abrogated Taxol-induced apoptosis, while inhibitors of other caspases partially blocked it.

Conclusions:

• Taxol induces apoptosis in lymphoblastic leukemia cells through an FADD-dependent pathway.
• The primary apoptotic pathway activated by Taxol involves caspase-10, independent of canonical death receptors.
• This study clarifies a key mechanism of Taxol's anti-cancer action.